Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 13 Dec 2017 for Ocera Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
DP VI Associates, L.P.: trading record in brief
DP VI Associates, L.P. discloses dealings in 4 companies, chiefly CoLucid Pharmaceuticals, Inc., Ocera Therapeutics, Inc. and Syndax Pharmaceuticals Inc. Over a trading history stretching from 8 March 2016 to 11 December 2017, the count stands at 7 filings.
On the market, this insider has only sold: 4 sales, €3,295 in total.
The latest filing, published on 13 December 2017, reports a transaction in Ocera Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to DP VI Associates, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
15,731 sharesCommon StockSEC:0000904454-17-000725:0
1,657 shares@ US$28.35100.0% of flowCommon StockSEC:0000904454-16-001533:0
84 shares@ US$8.8220.1% of flowCommon StockSEC:0000904454-16-001354:0
32 shares@ US$8.717.5% of flowCommon StockSEC:0000904454-16-001354:1
129 shares@ US$8.1528.6% of flowCommon StockSEC:0000904454-16-001354:2
235 shares@ US$6.9643.7% of flowCommon StockSEC:0000904454-16-001194:0
13,925 sharesCommon StockSEC:0000904454-16-001111:0
7 of 7 declarations
